BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 23928498)

  • 1. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
    Shu Y; Shu D; Haque F; Guo P
    Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
    Shu Y; Cinier M; Shu D; Guo P
    Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene.
    Qiu C; Peng WK; Shi F; Zhang T
    Genet Mol Res; 2012 Sep; 11(3):3236-45. PubMed ID: 23079817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
    Guo S; Tschammer N; Mohammed S; Guo P
    Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
    Haque F; Xu C; Jasinski DL; Li H; Guo P
    Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
    Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
    Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.
    Reif R; Haque F; Guo P
    Nucleic Acid Ther; 2012 Dec; 22(6):428-37. PubMed ID: 23113765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor.
    Guo S; Piao X; Li H; Guo P
    Methods; 2018 Jul; 143():121-133. PubMed ID: 29530505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grouping of ferritin and gold nanoparticles conjugated to pRNA of the phage phi29 DNA-packaging motor.
    Moll WD; Guo P
    J Nanosci Nanotechnol; 2007 Sep; 7(9):3257-67. PubMed ID: 18019159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.
    Abdelmawla S; Guo S; Zhang L; Pulukuri SM; Patankar P; Conley P; Trebley J; Guo P; Li QX
    Mol Ther; 2011 Jul; 19(7):1312-22. PubMed ID: 21468004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.
    Shu D; Khisamutdinov EF; Zhang L; Guo P
    Nucleic Acids Res; 2014 Jan; 42(2):e10. PubMed ID: 24084081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics.
    Shu D; Shu Y; Haque F; Abdelmawla S; Guo P
    Nat Nanotechnol; 2011 Sep; 6(10):658-67. PubMed ID: 21909084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of circular permutation to assess six bulges and four loops of DNA-packaging pRNA of bacteriophage phi29.
    Zhang C; Tellinghuisen T; Guo P
    RNA; 1997 Mar; 3(3):315-23. PubMed ID: 9056768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA.
    Zhang H; Endrizzi JA; Shu Y; Haque F; Sauter C; Shlyakhtenko LS; Lyubchenko Y; Guo P; Chi YI
    RNA; 2013 Sep; 19(9):1226-37. PubMed ID: 23884902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in Phi29 pRNA biology and its application in drug delivery.
    Ye X; Hemida M; Zhang HM; Hanson P; Ye Q; Yang D
    Wiley Interdiscip Rev RNA; 2012; 3(4):469-81. PubMed ID: 22362726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The structure, function and recent reseach of pRNA].
    Zhou H; Lu XY; Tian Y; Huang CJ
    Yi Chuan; 2006 Sep; 28(9):1180-4. PubMed ID: 16963432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modular assembly of chimeric phi29 packaging RNAs that support DNA packaging.
    Fang Y; Shu D; Xiao F; Guo P; Qin PZ
    Biochem Biophys Res Commun; 2008 Aug; 372(4):589-94. PubMed ID: 18514064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse self-association properties within a family of phage packaging RNAs.
    Hao Y; Kieft JS
    RNA; 2014 Nov; 20(11):1759-74. PubMed ID: 25246655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
    Shu Y; Cinier M; Fox SR; Ben-Johnathan N; Guo P
    Mol Ther; 2011 Jul; 19(7):1304-11. PubMed ID: 21468002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.